The current status of immunotherapy in peritoneal carcinomatosis.

about

Regional immunotherapy for liver and peritoneal metastases.

P2860

Q39329364-192DF6E2-9C6C-44E6-A8F9-BD3CA8ED0FEB

P2860

The current status of immunotherapy in peritoneal carcinomatosis.

Item

http://www.wikidata.org/entity/Q38830852

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The current status of immunotherapy in peritoneal carcinomatosis.

@en

type

Item

label

The current status of immunotherapy in peritoneal carcinomatosis.

@en

prefLabel

The current status of immunotherapy in peritoneal carcinomatosis.

@en

P1476

The current status of immunotherapy in peritoneal carcinomatosis.

@en

P2093

Karl-Walter Jauch

http://www.w3.org/2001/XMLSchema#string

Markus Maria Heiss

http://www.w3.org/2001/XMLSchema#string

Michael Alfred Ströhlein

http://www.w3.org/2001/XMLSchema#string

P2860

The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule

Continuous cultures of fused cells secreting antibody of predefined specificity

Alternative molecular formats and therapeutic applications for bispecific antibodies

Frequent EpCam protein expression in human carcinomas

Antibody therapy of cancer

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy

Normal human immune peritoneal cells: subpopulations and functional characteristics.

Simultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody.

P304

1019-1027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737140.2016.1224666

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27530056

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

The current status of immunotherapy in peritoneal carcinomatosis.

about

P2860

P2860

The current status of immunotherapy in peritoneal carcinomatosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921